Multisite phosphorylation of glycogen synthase from rabbit skeletal muscle Phosphorylation of site 5 by glycogen synthase kinase-5 (casein kinase-II) is a prerequisite for phosphorylation of sites 3 by glycogen synthase kinase-3 by Picton, Colin et al.
Volume 150. number 1 FEBS LETTERS December 1982 
Multisite phosphorylation of glycogen synthase from rabbit 
skeletal muscle 
Phosphorylation of site 5 by glycogen synthase kinase-5 (casein kinase-II) 
is a prerequisite for phosphorylation of sites 3 by glycogen synthase 
kinase-3 
Colin Picton*, James Woodgett, Brian Hemmings and Philip Cohen+ 
Department of Biochemistry, Medical Sciences Institute, University of Dundee, Dundee DDI 4HN, Scotland 
Received 4 November 1982 
Glycogen synthase kinase-5 (casein kinase-II) phosphorylates glycogen synthase on a serine termed site 5. 
This residue is just C-terminal to the 3 serines phosphorylated by glycogen synthase kinase-3, which are 
critical for the hormonal regulation of glycogen synthase in vivo. Although phosphorylation of site 5 does 
not affect the catalytic activity, it is demonstrated that this modification is a prerequisite for 
phosphorylation by glycogen synthase kinase-3. Since site 5 is almost fully phosphorylated in vivo under 
all conditions, the role of glycogen synthase kinase-5 would appear to be a novel one in forming the 
recognition site for another protein kinase 
Glycogen synthase Casein kinase Adrenalin Insulin Cyclic AMP Calmodulin 
1. INTRODUCTION 
Glycogen synthase is the best documented exam- 
ple of ‘multisite phosphorylation’, a phenomenon 
that is being encountered with increasing frequency 
[ 11. The enzyme is phosphorylated on 7 serine 
residues by 6 protein kinases [l-4]. Cyclic AMP- 
dependent protein kinase phosphorylates sites la, 
lb and 2 (site la >> site 2 > site lb), 
phosphorylase kinase, glycogen synthase kinase-4 
and a specific calmodulin dependent glycogen syn- 
thase kinase site 2, glycogen synthase kinase-3 sites 
(3a + 3b + 3c), and glycogen synthase kinase-5 site 
5. Site 2 is 7 residues from the N-terminus of the 
protein, while sites 3a, 3b, 3c, 5, la and lb are 30, 
34, 38, 46, 87 and 100 residues respectively from 
the N-terminus of a large cyanogen bromide pep- 
tide near the C-terminus of glycogen synthase [5]. 
The phosphorylation of glycogen synthase 
decreases its activity. Phosphorylation of sites 
(3a + 3b + 3c) or site 2 produces larger changes than 
site la, but the effects are cumulative, so that even 
greater decreases in activity are observed when all 
five sites are labelled. Phosphorylation of site lb or 
5 does not alter the kinetic properties [1,2]. 
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All 7 serine residues are phosphorylated in vivo 
[6]. Glycogen synthase isolated from normally fed 
or 24 h starved animals contains slightly <3 mol 
phosphate/m01 subunit of which >40% is present 
in sites (3a + 3b + 3c) [6,7]. Activation produced in 
vivo by acute administration of insulin is 
associated with the loss of 0.4-0.5mol phos- 
phate/mol subunit from sites (3a + 3b + 3c), 
without a significant change in the phosphate con- 
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tent of any other site [7]. Injection of adrenalin in- 
creases the phosphate content to slightly above 
5 mol/mol subunit. Most of the increase occurs at 
sites (3a+ 3b + 3c) (increased by -1.2mol phos- 
phate/mol subunit) and site 2 (increased by 
-0.6 mol phosphate/m01 subunit), with only small 
increases at sites la and lb (both increased by 
-0.25mol phosphate/m01 subunit) and none at 
site 5 [6]. 
The increased phosphorylation at sites 
(3a+ 3b + 3c) in response to adrenalin was unex- 
pected. The effects of this hormone are mediated 
by cyclic AMP in skeletal muscle, yet the activity 
of glycogen synthase kinase-3 is unaffected by this 
second messenger [2]. One possibility is that in- 
creased phosphorylation of sites 1 a, 1 b and 2 alters 
the conformation of glycogen synthase in such a 
way as to facilitate the phosphorylation of sites 
(3a + 3b + 3c) by glycogen synthase kinase-3. This 
idea prompted a systematic study of the effects of 
phosphorylation at one site, on the rates of 
phosphorylation of other sites. The results of these 
studies are reported here and demonstrate that sites 
(3a+ 3b + 3c) cannot be phosphorylated in vitro 
unless site 5 is phosphorylated. 
2. MATERIALS AND METHODS 
2. I. Protein preparations 
Glycogen synthase a [8,9], phosphorylase kinase 
[lo], glycogen synthase kinase-3 [ 111, glycogen 
synthase kinase-4 [2], glycogen synthase kinase-5 
[2], the catalytic subunit of cyclic AMP-dependent 
protein kinase [ 121 and its specific inhibitor protein 
[ 131, and the calmodulin-dependent glycogen syn- 
thase [3] were purified from rabbit skeletal muscle 
by standard procedures. A further sample of 
glycogen synthase kinase-5 (casein kinase-II) 
isolated from rabbit reticulocytes, was a gift from 
Dr Jolinda Traugh (Department of Biochemistry, 
University of California, Riverside). Calmodulin 
was purified from sheep brain. 
2.2. Phosphorylation of glycogen synthase a 
Preparations of glycogen synthase were passed 
through phosphocellulose to remove trace en- 
dogenous glycogen synthase activities [ 141. The 
assays (0.1 ml) were carried out at 0.4 mg glycogen 
synthase/ml in 50 mM Tris-HCl (pH 7.0)-O. 1% 
(v/v) 2-mercaptoethanol, 3.0 mM MgCL and 
0.1 mM [Y-~~P]ATP unless stated otherwise. 
EGTA (0.2mM) was present, except in reactions 
involving phosphorylase kinase and the 
calmodulin-dependent glycogen synthase kinase, 
which contained 0.1 mM CaCl2. Calmodulin 
(lOpg/ml) was added to assays of the calmodulin- 
dependent glycogen synthase kinase. The inhibitor 
protein and heparin (2pg/ml) were included in all 
incubations to inhibit any trace cyclic AMP- 
dependent protein kinase or glycogen synthase 
kinase-5 activity [2], respectively (except in reac- 
tions involving these two enzymes). The reactions 
were initiated with ATP and terminated and 
analysed as in [ 151. Reaction blanks in which. 
glycogen synthase kinase or glycogen synthase 
were omitted were included, but were negligible in 
virtually all the experiments. Rates of 
phosphorylation were generally linear up to 
O.l-0.2mol/mol subunit, and the extent of 
phosphorylation was kept within this limit. The 
phosphorylation stoichiometry was calculated as in 
[ 151. One unit of glycogen synthase kinase activity 
was that amount which catalysed the incorporation 
of 1 .O nmol phosphate/min into glycogen synthase 
a. 
2.3. Dephosphorylation of glycogen synthase a 
Glycogen synthase a (2mg/ml) was dialysed 
against 1OmM Tris-HCl (pH 6.5)-O. 1% (v/v) 
2-mercaptoethanol and incubated with potato acid 
phosphatase (4pg/ml) for 18h at 20°C to 
dephosphorylate site 5. Control incubations were 
carried out in which potato acid phosphatase was 
omitted. The alkali-labile phosphate contents of 
the preparations were determined. The dephospho- 
rylated and control preparations of glycogen syn- 
thase a were then phosphorylated by the different 
glycogen synthase kinases as in section 2.2., except 
that 1OmM potassium phosphate (pH 7.5) was in- 
cluded in the assays to completely inhibit potato 
acid phosphatase. Potato acid phosphatase was 
also added to the control preparations (after the 
addition of potassium phosphate) to ensure that 
the compositions of all incubations were identical. 
2.4. Materials and other analytical procedures 
The sources of all materials are given in [2]. The 
assay of glycogen synthase [7,16], and measure- 
ments of alkali labile phosphate [2,17] were carried 
out by standard procedures. 
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3. RESULTS 
3.1. Effect of site-5 phosphorylation on the rate 
of phosphorylation of glycogen synthase by 
different glycogen synthase kinases 
Preparations of glycogen synthase a with activity 
The dephosphorylated and control preparations 
of glycogen synthase a were tested for their ability 
to be phosphorylated by different glycogen syn- 
thase kinases. Dephosphorylation of glycogen syn- 
thase a did not affect the rate of phosphorylation 
of site 2 by phosphorylase kinase, glycogen syn- 
ratios + glucosedP of -0.8 still contain a con- 
siderable amount of alkali-labile phosphate 
(0.4-0.8 mol/mol subunit), located in the 2 sites 
that do not affect the kinetic properties (site 5 and 
site 1 b) [6]. Most of the phosphate (usually -75%) 
is in site 5 [6]. These sites are incompletely dephos- 
phorylated during the isolation of glycogen syn- 
thase a, because they are very poor substrates for 
the protein phosphatases present in skeletal muscle 
14,181. 
Incubation with potato acid phosphatase for 
18 h at 20°C (section 2.3.) released all the alkali- 
labile phosphate from glycogen synthase a (see fig. 
1) without any detectable change in the activity of 
the enzyme, measured in the presence or absence of 
glucose-6P. The glycogen synthase protein (MI 
86000) showed no sign of proteolysis after the in- 
cubations, as judged by the absence of degradation 
products (AYr 77 000 and 69000 [4,8], when examin- 
ed by SDS-polyacrylamide gel electrophoresis (not 
shown). These experiments confirm that 
phosphorylation of site 5 does not alter the kinetic 
properties of glycogen synthase. 
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Fig. 1. Phosphorylation of glycogen synthase a before 
(open symbols) and after (closed symbols) incubation 
with potato acid phosphatase. The glycogen synthase a 
preparation contained 0.8 mol phosphate/m01 subunit 
before, and < 0.02 mol phosphate/m01 subunit after in- 
cubation with potato acid phosphatase as in section 2: 
(A) phosphorylated with phosphorylase kinase (circles) 
and the calmodulin-dependent glycogen synthase kinase 
(triangles); (B) phosphorylated with glycogen synthase 
kinase-4 (circles) and cyclic AMP-dependent protein 
kinase (triangles); (C) phosphorylated with glycogen syn- 
Fig. 2. Effect of dephosphorylation and rephosphoryla- 
tion of site 5 on the rate of phosphorylation of glycogen 
synthase a by glycogen synthase kinase-3. Glycogen syn- 
thase a was treated with potato acid phosphatase (section 
2.3.) and contained <O.O4mol phosphate/m01 subunit. 
An aliquot of the preparation (0.4mgIml) was 
phosphorylated to 0.45 mol/mol subunit with glycogen 
synthase kinase-5 in 50mM Tris-HCl (pH 7.5) contain- 
ing 1OmM potassium phosphate (pH 7.5) 200 mM NaCl, 
inhibitor protein, 0.2mM EGTA, 6.0mM Mg2+ and 
0.05 mM ATP (unlabelled). The phosphorylation 
stoichiometry was established by a separate parallel in- 
cubation with [y-32P]ATP. The reaction (0.07ml) ap- 
proached a plateau after 30min and was terminated by 
the addition of a 0.1 mg/ml solution of heparin 
(0.01 ml). Glycogen synthase kinase-3 was added, 
followed by l.OmM [y-3ZP]ATP (0.01 ml). (w) 
Glycogen synthase a preparation not treated with potato 
acid phosphatase nor phosphorylated by glycogen syn- 
thase kinase-5; (U) glycogen synthase II preparation 
incubated with potato acid phosphatase and 
rephosphorylated with glycogen synthase kinase-5; 
(o---o) glycogen synthase II treated with potato acid 
phosphatase, but not rephosphorylated with glycogen 
thase kinase-3. synthase kinase-5. 
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thase kinase-4 and the calmodulin-dependent 
glycogen synthase kinase, or the phosphorylation 
of site la by cyclic AMP-dependent protein kinase 
(figs. lA,B) but virtually abolished phosphoryla- 
tion of the enzyme by glycogen synthase kinase-3 
(fig. 1C). Rephosphorylation of site 5 with 
glycogen synthase kinase-5, restored the ability to 
be phosphorylated by glycogen synthase kinase-3 
(fig. 2). 
2.5 5.0 7.5 10 
time (mid 
Fig. 3. Effect of phosphorylation by cyclic AMP- 
dependent protein kinase (triangles) or phosphorylase 
kinase (circles) on the rate of phosphorylation of 
glycogen synthase by glycogen synthase kinase-3. 
Glycogen synthase was phosphorylated with the catalytic 
subunit of cyclic AMP-dependent protein kinase 
(lOU/ml) to 2.15mol/mol subunit [site la = 0.7, site 
lb = 0.65, site 2 = 0.8mol/mol subunit [23] or with 
phosphorylase kinase (lOpg/ml) to 0.45 mol/mol 
subunit, using the phosphorylation assay described in 
section 2.2. except that unlabelled ATP was used. The 
phosphorylation stoichiometries were established by 
separate parallel incubations with [y-32P]ATP. The reac- 
tions were terminated by the addition of either the in- 
hibitor protein or 5.0mM EGTA (0.01 ml). Glycogen 
synthase kinase-3 (5~1) was then added, followed by 
1 .O mM [T-~‘P]ATP (0.01 ml). Rates of phosphorylation 
(open symbols) were then compared to control incuba- 
tions (closed symbols) in which either cyclic AMP- 
dependent protein kinase or phosphorylase kinase had 
been omitted. 
3.2. Effect of phosphorylation of sites la, 
lb and 2 on the rate of phosphorylation 
of sites (3a + 3b + 3~) 
Phosphorylation of sites la, lb and 2 by cyclic 
AMP-dependent protein kinase or site 2 with 
phosphorylase kinase had no effect on the rate of 
phosphorylation of sites (3a + 3b + 3c) by glycogen 
synthase kinase-3 (fig. 3). Conversely phosphoryla- 
tion of sites (3a+ 3b + 3c) by glycogen synthase 
kinase-3 did not affect the rate of phosphorylation 
of site 2 by phosphorylase kinase, glycogen syn- 
thase kinase-4 or the calmodulin-dependent glyco- 
gen synthase kinase or site la by cyclic AMP-de- 
pendent protein kinase (not shown). 
The inclusion of glycogen (lOmg/ml) or 
glucosedP (1 .OmM) in the assays did not 
significantly affect the activity of any glycogen 
synthase kinase (not shown). 
4. DISCUSSION 
Glycogen synthase kinase-5 [2] is identical to an 
enzyme that has a ubiquitous tissue distribution, 
and has been variously termed casein kinase TS 
[ 191, casein kinase-II [20], casein kinase-G [21], ca- 
sein kinase N-II [22] and troponin-T kinase 
[23,24]. Several physiological substrates of this en- 
zyme have been identified including glycogen syn- 
thase [6,7], the Rn-subunit of cyclic AMP- 
dependent protein kinase [25,26] and troponin-T 
[24,27] in muscle, and the,&subunit of protein syn- 
thesis initiation factor eIF-2 in reticulocytes 
[28,29]. However, the function of glycogen syn- 
thase kinase-5 has remained problematic, since 
none of the above phosphorylations appear to 
modify the activities of these proteins. Further- 
more, all the physiological substrates as normally 
isolated contain substantial amounts of phosphate 
in the site(s) phosphorylated by glycogen synthase 
kinase-5, even though no precautions are taken to 
prevent the action of endogenous protein 
phosphatases. These sites therefore seem to be ex- 
tremely poor substrates for protein phosphatases 
in mammalian tissues, suggesting that they may be 
rather stable modifications that do not turn over 
rapidly in vivo. This certainly appears to be the 
case for glycogen synthase, since phosphorylation 
of site 5 is not significantly affected by acute ad- 
ministration of adrenalin and insulin, or by 
starvation-refeeding [6,7]. 
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This work suggests that one of the functions of 
glycogen synthase kinase-5 is to phosphorylate 
residues that can then act as recognition sites for 
glycogen synthase kinase-3 (and perhaps other pro- 
tein kinases). This idea is supported by recent 
studies of the phosphorylation of the Rrr-subunit 
of cyclic AMP-dependent protein kinase. Glycogen 
synthase kinase-5 phosphorylates serine-74 and 
serine-76, and glycogen synthase kinase-3 serine-44 
and serine-47. However, the rate of phosphoryla- 
tion of serine-44/serine-47 is decreased at least 
lo-fold, if serines-74 and 76 are first dephosphory- 
lated [25]. 
The phosphorylation of glycogen synthase a by 
glycogen synthase kinase-3 in vitro generally 
reaches a plateau at 1.0-l .5 mol/mol subunit, 
despite the fact that 3 serine residues are phospho- 
rylated [ll, 151. Furthermore, at the end of the 
reaction the tryptic peptide containing sites 
(3a + 3b + 3c) is entirely in the triply phosphorylat- 
ed state [l 11. This puzzling result can now be ex- 
plained, since the phosphorylation of glycogen 
synthase kinase-3 will plateau at a level determined 
by the extent of phosphorylation of site 5. The pre- 
sent work can also account for the failure of 
glycogen synthase kinase-3 to phosphorylate a 
synthetic hexadecapeptide containing sites 
(3a + 3b + 3c) but not site 5 [l I]. 
Glycogen synthase kinase-3 phosphorylates the 
Rrr-subunit of cyclic AMP-dependent protein 
kinase at lo-15% of the rate of glycogen synthase 
[25], but 9 further proteins that are excellent 
substrates for other protein kinases are not phos- 
phorylated at all [ 11,151. The necessity for a phos- 
phoserine residue C-terminal to the sites phospho- 
rylated by glycogen synthase kinase-3 may underlie 
its high specificity. It may also explain why 3 close- 
ly spaced serine residues in glycogen synthase are 
phosphorylated by this enzyme. On the other 
hand, the specificity of glycogen synthase kinase-3 
may now need to be re-examined if potential 
substrates must first be phosphorylated by 
glycogen synthase kinase-5 (or other protein 
kinases) . 
The rate of phosphorylation of sites (3a + 3b + 
3c) was unaffected by prior phosphorylation of 
sites la, lb and 2 (fig. 3) or vice versa. The increas- 
ed phosphorylation of sites (3a+ 3b+3c) that oc- 
curs in vivo in response to adrenalin cannot 
therefore be explained by this mechanism, and is 
LETTERS December 1982 
most likely to involve an inhibition of protein 
phosphatase- 1 [ 1,6]. 
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